Thus we aimed to evaluate the immunohistochemical expression of MCM-2 in abnormal cervical epithelium in women with and without HIV-1 co-infection to determine if MCM-2 is a valid prognostic biomarker for cervical cancer. The gene discussed is MCM2; the disease is cervical cancer.